Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that acts by inhibiting the synthesis of prostaglandins. It has a dosage of 30 mg every 6 hours. Ketorolac should only be used for up to 5 days total and oral use is only for continuing intravenous or intramuscular therapy. Intramuscular injections in patients with coagulation issues or those on anticoagulants may cause bleeding and hematomas. Common adverse effects include central nervous system issues like drowsiness, gastrointestinal issues like nausea and peptic ulcers, and renal failure.
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that acts by inhibiting the synthesis of prostaglandins. It has a dosage of 30 mg every 6 hours. Ketorolac should only be used for up to 5 days total and oral use is only for continuing intravenous or intramuscular therapy. Intramuscular injections in patients with coagulation issues or those on anticoagulants may cause bleeding and hematomas. Common adverse effects include central nervous system issues like drowsiness, gastrointestinal issues like nausea and peptic ulcers, and renal failure.
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that acts by inhibiting the synthesis of prostaglandins. It has a dosage of 30 mg every 6 hours. Ketorolac should only be used for up to 5 days total and oral use is only for continuing intravenous or intramuscular therapy. Intramuscular injections in patients with coagulation issues or those on anticoagulants may cause bleeding and hematomas. Common adverse effects include central nervous system issues like drowsiness, gastrointestinal issues like nausea and peptic ulcers, and renal failure.
Generic/ Brand Classification Mechanism of Action Consideration/ What to Adverse Effect
Observe/ Look
Pharmacologic Ketorolac is an NSAID • Correct hypovolemia CNS: drowsiness,
Ketorolac classification: NSAID that acts by inhibiting before starting therapy sedation, dizziness, headache the synthesis of with ketorolac. . Dosage: 30 mg. / Q6 º Therapeutic prostaglandins. • The combined CV: edema, hypertension, classification: analgesic duration of ketorolac palpitations, arrhythmias. I.M., I.V., or P.O. GI: nausea, dyspepsia, GI Pregnancy risk category shouldn’t exceed 5 pain, diarrhea, peptic C days. Oral use is only ulceration, vomiting, for continuation of I.V. constipation, flatulence, or I.M. therapy. stomatitis. • I.M. injections in GU: renal failure. patients with Hematologic: decreased coagulopathies or those platelet adhesion, receiving purpura, thrombocytopenia. anticoagulants may Skin: pain at injection site, cause bleeding and pruritus, rash, diaphoresis. hematoma at the injection site.